Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

NCT06110208 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Collaborator's decision

Conditions

Interventions

Sponsor

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Collaborators